SCHEMBL6946002

SCHEMBL6946002

CCCC1=NN(c2ccc([N+](=O)[O-])cc2)C(=O)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 12/20 0.55
MEN1 O00255 10/20 0.55
KMT2A Q03164 10/20 0.55
GAA P10253 4/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
ALDH1A1 P00352 9/20 0.54
POLB P06746 2/20 0.54
HTT P42858 1/20 0.54
SHMT2 P34897 1/20 0.54
KDM4E B2RXH2 3/20 0.52
BLM P54132 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.44
PKM P14618 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.42
AMY1A P0DUB6 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
MAOB P27338 1/20 0.41
NPC1 O15118 2/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8425391 0.84 GAA (0.43) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL5976250 0.83 SHMT2 (0.62) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL5462191 0.83 MAPT (0.54) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL8015635 0.82 MAPT (0.54) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL5976498 0.80 SHMT2 (0.59) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL5975777 0.80 KMT2A (0.60) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL5975717 0.80 SHMT2 (0.59) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL4664734 0.80 SHMT2 (0.82) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL27367274 0.79 GAA (0.55) MAPTMEN1KMT2AGAAL3MBTL1
SCHEMBL14559421 0.79 SHMT2 (0.57) MAPTMEN1KMT2AGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743304-B1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed
US-6034099-A Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones CELL PATHWAYS, INC. (US) 2000-03-07 US disclosed
EP-0743304-A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones MERCK PATENT GmbH (DE) 1996-11-20 EP disclosed